FDA-Drug2026-04-15Class IIPROCESSING DEFECT

Fresenius Kabi sodium chloride injection recalled for sterility concerns

OTHERNationwide distributionDrugs

What this means

Fresenius Kabi USA is recalling specific batches of 0.9% Sodium Chloride Injection (saline) because the manufacturer cannot confirm the product is sterile. Sterility is critical for injectable medications. The affected batches have expiration dates of October 31, 2026, or November 30, 2026.

  • Check your saline injection bottles for batch numbers 6402428, 6402481, or 6402482 and the expiration dates listed above.
  • Do not use affected bottles. Contact your healthcare provider or pharmacy for replacement.
  • If you have already used saline from these batches, inform your healthcare provider.
The agency's original wording
Hazard

Lack of Assurance of Sterility

Intended for
All ages (0 months and older)
Illnesses reported
None reported
Sold states
US Nationwide , Alaska, and Puerto Rico.
Manufactured in
3 Corporate Dr, Lake Zurich, IL, United States
Products
0.9% Sodium Chloride Injection, USP, 50 mL x60, Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417 USA, Distributed by BD, Manufactured by Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-02.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0429-2026

More Fresenius Kabi recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime